🇺🇸 palonesetron in United States
15 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 15
Most-reported reactions
- Hypotension — 3 reports (20%)
- Erythema — 2 reports (13.33%)
- Pyrexia — 2 reports (13.33%)
- Sepsis — 2 reports (13.33%)
- Anaphylactic Reaction — 1 report (6.67%)
- Chest Discomfort — 1 report (6.67%)
- Diarrhoea — 1 report (6.67%)
- Drug Ineffective — 1 report (6.67%)
- Dyspnoea — 1 report (6.67%)
- Headache — 1 report (6.67%)
Other Other approved in United States
Frequently asked questions
Is palonesetron approved in United States?
palonesetron does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for palonesetron in United States?
Eisai Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.